Market Newsdesk

Warrant acceleration has a potential value of
approximately
USD
$
30
million in gross proceeds to the Company

Gross proceeds further bolster strong balance sheet and Company’s plans to aggressively expand its market share

BOCA RATON, Fla., Nov. 24, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it has exercised its right to accelerate the expiry date of subordinate voting share purchase warrants (the “Warrants”) issued to participants in the Company’s previously-announced private placement offerings, which closed in April 2018 and June 2018 (the “Offerings”). Participants have thirty days from the date of notice of the acceleration to exercise their Warrants.

Each Warrant issued in conjunction with the Offerings entitled the holder to purchase one subordinate voting share in the capital of Jushi for a period of 24 months from June 10, 2019 (i.e. June 10, 2021) at an exercise price of USD$2.00 per share, subject to adjustment in certain events. Jushi retained the right to require the acceleration of the expiry date of these Warrants if the Company’s twenty-trading-day volume-weighted-average-price (“VWAP”) on the Canadian Securities Exchange (CSE) exceeded USD$3.00 (“Accelerated Expiry Date”). This was achieved during the trading period from October 27, 2020 through November 23, 2020. Management expects redemptions of the Warrants to result in the issuance of approximately 15 million additional subordinate voting shares and cash proceeds of approximately USD$30 million, however, there can be no assurance that any of the Warrants will be exercised prior to the Accelerated Expiry Date.

Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi

, commented, “Jushi continues to build scale and tactically expand our footprint in both our current and developing markets, with a focus on high quality, limited license opportunities. We are grateful for the continued support of our shareholders and expect to leverage these proceeds together with our strong balance sheet to accelerate our growth while continuing to generate strong shareholder value.”

Warrant holders who wish to exercise their Warrants should contact their investment advisor and submit an exercise notice form to Jushi’s Investor Relations Department at [email protected]. Any Warrants that have not been exercised by 5:00 p.m. (eastern time) at the end of 30 days notice will automatically be cancelled.

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, involve estimates, projections, plans, goals, forecasts and assumptions that may prove to be inaccurate. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has certain expectations and has made certain assumptions. Expectations, assumptions and risk factors are more fully described in the Company’s Management, Discussion and Analysis for the three months ended September 30, 2020, and other filings with securities and regulatory authorities which are available at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Not for distribution to United States newswire services or for dissemination in the United States.

For further information, please contact:

Investor Relations Contact:

Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-453-1308
[email protected]

Media Contact:

Ellen Mellody
MATTIO Communications
570-209-2947
[email protected]

MONTREAL, Nov. 24, 2020 (GLOBE NEWSWIRE) — Dessert Advisor, an online platform connecting foodies and dessert retailers, announces the availability of the biggest Christmas dessert repository in Canada. Concerned with all things sweet or baked, Dessert Advisor has compiled a database of thousands of retailers and dessert items designed to facilitate the search for delicious desserts located close by, connecting retailers across Canada with new clients that would otherwise be unaware of their sweet offerings.

As Canadians prepare for a possible Christmas lockdown, they also find themselves unable to travel, missing out on valuable contact with family members and friends. The social gathering restrictions coupled with the frustrating prospect of yet more isolation and uncertainty mean individuals are having to forfeit a number of holiday traditions. In an attempt to comfort Canadians in times of stress, Dessert Advisor is here to assist Canadians with the tradition of Christmas desserts, one that does not have to fall by the wayside.

The announcement of Dessert Advisor’s Christmas dessert repository comes at a time when individuals need to reduce their shopping time outside of the house. Some people don’t know how to make butter tarts or they’re unaware that the time to start making fruitcakes has already passed. “We normally leave these jobs to older family members who proudly carry the tradition year after year,” says Gil Gruber, Founder of DessertAdvisor.com. “This year is different, and for the safety of our older relatives, we have to find other ways to satiate our holiday cravings. This is where DessertAdvisor.com steps in. With the largest Christmas dessert repository in Canada, it takes the guesswork out and saves you time by connecting you with specific dessert choices and retailers,” he adds.

The Dessert Advisor website maintains a list of over one million desserts across Canada. It is unique in that it offers dessert retailers a complimentary listing of their products, providing them with increased online visibility of the dessert products themselves, not just their shop locations. With just one click, foodies are now able to search for their specific dessert craving and find a local retailer that can satisfy their immediate needs. This ability to bridge the gap between hungry consumers and challenged dessert businesses is one way this site is helping to ease some of the COVID-19 related stress.

Dessert Advisor invites foodies to search for their favourite Christmas dessert based on their dietary requirements, add reviews, and support their local dessert retailers. Dessert retailers are asked to check if their businesses are listed on the site and confirm whether their products are featured under their listing. Retailers are encouraged to upload any of their missing dessert products in order to gain higher exposure.

About Dessert Advisor

Dessert Advisor
is a community that bridges the gap between foodies and dessert/baked goods/chocolate/ice cream/snack retailers. With thousands of retailers and over one million dessert items listed on the platform, individuals can search for a specific dessert item and review it after they have tasted it. The Dessert Advisor platform enables dessert retailers to broaden their reach to new clients.

Contact:
Gil Gruber
Dessert Advisor
Tel: (514) 667-7011
Email: [email protected]
Https://DessertAdvisor.com

 

WINNIPEG, Manitoba, Nov. 24, 2020 (GLOBE NEWSWIRE) — KidSport™ has launched their ninth annual Give the Gift of Sport™ fundraising campaign, calling on Canadians to donate online at KidSport.ca/GiftofSport. Over 30 percent of Canadian youth under the age of 18 cannot afford to play organized sport. With the support of the Government of Canada, corporate partners, and the generosity of donors across the country, KidSport’s annual campaign—running until January 4, 2021—aims to get more kids off the sidelines, into the game, and experience the gift of sport.

“Organized sport provides our children with so many benefits. We know it can help them be healthier, but it can also help them with things like their education and social development,” says Jamie Ferguson, Chair of KidSport. “In essence, sport can provide our children with a head start on life. At KidSport we believe every child deserves that chance. Please give to our Give the Gift of Sport campaign and help make more head starts happen.”

The power of sport is in how it shapes us in those special moments – in the memories cherished today and stories told tomorrow. It nurtures our growth and strengthens our communities. “Sport has been the driving factor in shaping who I am, it has taught me all sorts of life skills and gave me the confidence to set goals and dream big when I was a kid,” adds Canadian race walker and Olympian Evan Dunfee. “KidSport believes that every child should have that same opportunity and help remove the financial barriers to make that happen.”

Since its creation in 1993, KidSport has disbursed over $84M and helped over 930,000 kids from coast to coast to coast receive grants and sport introduction programming. Bryan Ezako, KidSport Canada National Manager says that now more than ever, kids need sport! “Not only for the thrill of the game, but to help strengthen their mental and emotional health.” Families are facing financial strains like never before, “so we need to work together to ensure all kids get to experience the joys of being part of a team,” Ezako adds.

This year, by giving the gift of sport that you received as a kid, you can help create lasting memories and fill the gap for other kids who want to play. Help bring the power of sport Full Circle and Give the Gift of Sport at KidSport.ca/GiftofSport where personal, corporate or tribute donations can be directed to any of KidSport’s 166 community chapters.

About KidSport:

KidSport is a national not-for-profit organization that helps remove financial barriers that prevent kids from playing sport by providing assistance for registration fees and sport equipment to children aged 18 and under. Through a confidential application process grants are given so they can play a season of sport. Learn more about KidSport and join the holiday conversation on Twitter @KidSport and #GiftofSport, Facebook.com/KidSportCanada, Instagram.com/kidsport.canada or online at KidSport.ca/GiftofSport.

For more information:

Bryan Ezako
Manager, KidSport
[email protected]
204.925.5914

MISSISSAUGA, Ont., Nov. 24, 2020 (GLOBE NEWSWIRE) — MISSISSAUGA, Ont., November 24, 2020 – Five Ontario schools in the Greater Toronto Area (GTA) have received $50,000 worth of technology from Sharp Electronics of Canada as part of its Sharp@School pilot program. The company is providing calculators, collaboration and professional displays and air purifiers to ensure students at elementary and high schools have equitable access to tools for learning and to help with student success.

The participating schools include Monarch Park Collegiate Institute, Lakeshore Collegiate Institute, Etobicoke School of the Arts and James S. Bell Junior Middle Sports and Wellness Academy in the Toronto District School Board (TDSB); and Our Lady of the Rosary Catholic Elementary School in the York Catholic District School Board (YCDSB).

In many cases, access to technology depends on students’ ability to bring their own devices to school. Providing calculators to students in need will help them be successful and reduce distractions from phones. Sharp’s EL243SBcalculators will support numeracy programs in Grade 3 and above and EL501XBWH and ELW516XGBSL scientific calculator models will support high school students as they learn complex functions in Grade 9 and throughout their high school careers. Sharp has donated almost 2,000 calculators to the schools.

According to Karen Doherty Ross, Secondary Teacher, Assistant Curriculum Leader of Mathematics, Monarch Park Collegiate Institute, “Providing a calculator to junior students equips them with a tool they will use throughout their high school life and beyond. It also promotes responsibility and access to mathematics, encouraging continued studies throughout high school and post-secondary. With the new challenges we face this school year, the Sharp donation will help us ensure students do not need to share calculators. As mentioned, our junior students will keep the calculators throughout their high-school career. Senior students in need of a calculator will be loaned a calculator for the full quadmester to support math and science courses.”

“We’re very excited to be a part of this pilot program. Our hope is to create an equitable learning environment so technology can be equally accessed and used to support student learning and success,” said Melissa Michailidis, Mathematics Department, Etobicoke School for the Arts. “Getting students familiar with a calculator model in Grade 9 makes for a smoother transition as they progress into more advanced classes, and allows them to be well prepared for the future.” 

During the pandemic, students have been asked to minimize what they bring to school and to reduce the number of items they share for safety reasons. “By having that resource in their classroom, students no longer have to worry about bringing their own or sharing with others,” added Michailidis.  

The donation of a Sharp AQUOS Board® collaboration display will provide students at Lakeshore Collegiate Institute with the chance to work together on a large digital canvas, creating opportunities for creativity and collaboration.

In other schools, professional displays will be used to share announcements and student accomplishments and improve access to information for the student body. For mathematics departments, teachers will use the displays to share locations of extra help for students in need and math challenges/solved problems of the week.

Sharp has also donated air purifiers for use in classrooms without windows. 

“We’re delighted to launch our ‘Sharp@School’ pilot program to help students and teachers in our community, providing access to tools and equipment that will enhance education,” said Carmine Cinerari, President, Sharp Electronics of Canada. “Technology such as collaboration displays and calculators can have an immense impact on how students learn and work together, and how teachers can educate. We’re proud to launch this program, and to improve learning environments in classrooms across the GTA.”

To learn more about the Sharp@School initiative and specific donation details, visit https://sharpsimplybetterliving.ca/2020/11/23/inaugural-sharpschool-program-helps-five-ontario-schools-improve-access-to-technology/

Additional Quotes

“A high-resolution, interactive, multi-touch display board will make it easier to communicate complex concepts to students. It also allows students to communicate their ideas or share their work with the class. During the hybrid teaching model after the COVID-19 closure, it will allow some students to participate in lessons remotely while at home.”

Anthony Meli, Assistant Curriculum Leader, Mathematics and Numeracy, Lakeshore Collegiate Institute

“The Sharp professional display will become our very own digital display case. Health and Safety reminders relating to YCDSB and York Region Public Health COVID-19 pandemic protocols, local school initiatives, samples of student work and updated monthly news are some of the ways in which the Sharp display will be used by the school community. The school may also communicate its anti-bullying initiatives and announce our monthly Virtue Awards which celebrate the success of students who demonstrate great character. Staff and administration will use it to highlight school board updates and other school-related news. The vision is to create slideshows highlighting all the exciting things that are happening at our school to keep school staff, students and visitors up-to-date.”
Diana Di Vincenzo, Grade 7/8 Teacher; and W. H Kwon, Principal of Our Lady of the Rosary Catholic Elementary School

About Sharp Electronics of Canada Ltd.

Sharp Electronics of Canada Ltd. is the Canadian subsidiary of Sharp Corporation – a global developer and manufacturer of one-of-a-kind premium technology products. At Sharp, our challenge is to create a balance between work time and personal time, with products that benefit people’s lives at work, at home, and everywhere in between. Sharp Electronics of Canada Ltd. is dedicated to facilitating this improvement through advanced technology and a commitment to innovation, quality, value, and design. Learn more at http://www.sharp.ca/.

Become a fan of Sharp Electronics of Canada and follow us on Facebook, Twitter, LinkedIn and YouTube, or find more information here.

-30-

For more information:

Steve Gold/Cindy Watson

StrategicAmpersand (for Sharp Electronics of Canada)

[email protected]

Steve Gold
Sharp Electronics of Canada Ltd.
416-961-5595
[email protected]

BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that its chief executive officer, Bobby Gaspar, M.D., Ph.D. will participate in a pre-recorded fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings on Tuesday, December 1, 2020.

The fireside chat is available for on-demand viewing under “Events” in the Investors & Media section of the company’s website at www.orchard-tx.com and will remain available for approximately 90 days.

About Orchard

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. In 2018, Orchard acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.

Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com, and follow us on Twitter and LinkedIn.

Availability of Other Information About Orchard

Investors and others should note that Orchard communicates with its investors and the public using the company website (www.orchard-tx.com), the investor relations website (ir.orchard-tx.com), and on social media (Twitter and LinkedIn), including but not limited to investor presentations and investor fact sheets, U.S. Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Orchard posts on these channels and websites could be deemed to be material information. As a result, Orchard encourages investors, the media, and others interested in Orchard to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Orchard’s investor relations website and may include additional social media channels. The contents of Orchard’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Contacts

Investors

Renee Leck
Director, Investor Relations
+1 862-242-0764
[email protected]

LORDSTOWN, Ohio, Nov. 24, 2020 (GLOBE NEWSWIRE) — Lordstown Motors Corp. (Nasdaq: RIDE), (“Lordstown Motors”), a leader in electric light duty trucks focused on the commercial fleet market, today announced that Carter Driscoll has joined Lordstown Motors as Head of Investor Relations. In this capacity, Mr. Driscoll will be the main point of contact for Lordstown Motors shareholders, and will be responsible for managing and fostering relationships across the investment and analyst communities.

“I am thrilled to welcome Carter to our team. He brings with him experience that will be critical in helping us successfully grow as a public company,” commented Steve Burns, Chief Executive Officer of Lordstown Motors. “Carter’s more than two decades of experience as an investment professional and his focus on clean and sustainable technologies will be invaluable in helping our company tell its story, which is about building the most cost-effective, safest, zero emission work trucks ever made,” Mr. Burns continued.

Mr. Driscoll joins Lordstown Motors after an extensive career in the clean technology and investment communities. Most recently, Carter worked as a consultant for Enphase Energy, where he built out its comprehensive Investor Relations strategy. Prior to that, he spent more than 20 years in the investment world, working in equity research on both the buy-side and sell-side. His most recent role in the investment community was as a Clean & Sustainable Technologies research analyst at FBR (now B. Riley FBR). Mr. Driscoll’s experience includes roles in a similar capacity across several other investment banks as well. Prior to covering Alternative Energy, he covered the Technology, Media & Telecom sector for nine years at several firms, including the Stanford Group Company and IRG Research. He received his B.A. from Hamilton College and his M.B.A. from the University of Rochester.

About Lordstown Motors Corp.

Lordstown Motors Corp. is an Ohio-based original equipment manufacturer of light duty fleet vehicles, founded by CEO Steve Burns with the purpose of transforming Ohio’s Mahoning Valley and Lordstown, Ohio, into the epicenter of electric-vehicle manufacturing. The company owns the 785 acre, 6.2 million square foot Lordstown Assembly Plant where it plans to build the Lordstown Endurance, believed to be the world’s first full-size, all-electric pickup truck designed to serve the commercial fleet market. For additional information visit www.lordstownmotors.com.

Forward Looking Statements

This press release includes forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “feel,” “believes,” “expects,” “estimates,” “projects,” “intends,” “should,” “is to be,” or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein due to many factors, including, but not limited to: our limited operating history and our significant projected funding needs; risks associated with the conversion and retooling of our facility and ramp up of production; our inability to obtain orders from customers and potential customers’ inability to integrate our electric vehicles into their existing fleets; our inability to retain key personnel and to hire additional personnel; competition in the electric pickup truck market; our inability to develop a sales distribution network; and the ability to protect our intellectual property rights. Any forward-looking statements speak only as of the date on which they are made, and Lordstown Motors Corp. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Contacts:

Investors

Carter Driscoll
[email protected]

Media

Ryan Hallett / Leigh Harmon
[email protected]

RESEARCH TRIANGLE PARK, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that incoming Chief Executive Officer Jack Bailey and Chief Medical Officer and Senior Vice President, R&D Raj Malik, M.D. will present a company update at the Evercore ISI 3^rd Annual HealthCONx Conference on December 3, 2020 at 1:00 p.m. ET.

To access the live and archived webcast of the presentation, please visit the Events & Presentations page of the G1 website.

About G1 Therapeutics

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer. The company is developing and advancing two novel therapies: trilaciclib is a first-in-class therapy designed to improve outcomes for patients being treated with chemotherapy; rintodestrant is a potential best-in-class oral selective estrogen receptor degrader (SERD) for the treatment of ER+ breast cancer. In 2020, the company out-licensed global development and commercialization rights to its differentiated oral CDK4/6 inhibitor, lerociclib.

G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contact:

Jeff Macdonald
G1 Therapeutics, Inc.
Senior Director, Investor Relations & Corporate Communications
919-907-1944
[email protected]

JINHUA, China, Nov. 24, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company” or “Kandi”) (NASDAQ GS: KNDI), today announced that it closed the registered direct offering of 8,849,560 units (the “Units”) of its securities at a purchase price per Unit of $11.30 on November 23, 2020, as previously announced on November 20, 2020.  The offering generated aggregate gross proceeds to the Company of approximately $100 million, before deducting fees to the placement agent and other estimated offering expenses payable by the Company.  Each Unit consisted of one share of our common stock, and 0.4 warrants to purchase a share of our common stock.  The warrants have an exercise price of $14.50 per share, a term of 30 months, are  exercisable upon issuance.  The Company issued a total of 8,849,560 shares of common stock and warrants for the purchase of up to 3,539,825 shares of common stock to the investors in the offering. 

The net proceeds from this offering will be used for general working capital purposes including research and development for EV sports car models and expenditures necessary to ensure that our EV models comply with all necessary requirements for the entry into the U.S. market.    

FT Global Capital, Inc. acted as the exclusive placement agent for the transaction.

Pryor Cashman LLP acted as counsel to the Company and Schiff Hardin LLP acted as counsel to the placement agent in connection with the offering.  PacGate Law Group provided due diligence services to the placement agent in connection with the offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, and these securities cannot be sold in any state in which this offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. All offers were made only by means of a prospectus, including a prospectus supplement pursuant to the Company’s effective shelf registration statement and base prospectus contained therein. The shelf registration statement (SEC Filing No. 333-249585) relating to the offering was filed with and declared effective by the Securities and Exchange Commission (the “SEC”) on October 29, 2020. A prospectus supplement related to the offering was filed with the SEC on November 20, 2020 and is available at www.sec.gov.

For further details of this transaction, please see the Current Report on Form 8-K filed with the SEC on November 20, 2020 which may be viewed at www.sec.gov.

About Kandi Technologies Group, Inc.  

Kandi Technologies Group, Inc. (KNDI), headquartered in Jinhua Economic Development Zone, Zhejiang Province, is engaged in the research, development, manufacturing, and sales of various vehicular products. Kandi conducts its primary business operations through its wholly-owned subsidiary, Zhejiang Kandi Vehicles Co., Ltd. (“Kandi Vehicles”) and its subsidiaries including Zhejiang Kandi Smart Battery Swap Technology Co., Ltd, SC Autosports, LLC (d/b/a Kandi America), the wholly-owned subsidiary of Kandi in the United States and Fengsheng Automobile Technology Group Co., Ltd (formerly known as Kandi Electric Vehicles Group Co., Ltd., the “Affiliate Company”). Kandi Vehicles has established itself as one of China’s leading manufacturers of pure electric vehicle parts and off-road vehicles.

In 2013, Kandi Vehicles and Geely Group, China’s leading automaker, jointly invested in the establishment of the Affiliate Company in order to develop, manufacture and sell pure electric vehicle (“EV”) products. Geely Group (including its affiliate) and Kandi Vehicles currently hold 78% and 22% of the equity interests in the Affiliate Company, respectively. The Affiliate Company has established itself as one of the driving forces in the development and the manufacturing of pure EV products in China.

More information about KNDI is available on the Company’s corporate website at http://www.kandivehicle.com. The Company routinely posts important information on its website.

Safe Harbor Statement 

This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,””expects” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

Follow us on Twitter: @ Kandi_Group

For More Information:

Kandi Technologies Group, Inc.

Ms. Kewa Luo

Phone: +1 (212) 551-3610

Email: [email protected]

The Blueshirt Group

U.S.:

Mr. Gary Dvorchak

Email: [email protected]

China:

Ms. Susie Wang

Email: [email protected]

BURLINGAME, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two virtual investor conferences in December.

Piper Sandler
32

^nd

Annual
Virtual
Healthcare Conference

Format: Fireside chat with covering analyst, Chris Raymond
Date: November 30 – December 3
Webcast link: Available here

3rd Annual Evercore ISI HealthCONx Conference

Format: Fireside chat with analyst, Umer Raffat
Date: Thursday, December 3
Time: 10:30 AM Eastern Time
Webcast link: Available here

A live webcast of the Evercore fireside chat and a recording of the Piper Sandler fireside chat can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcasts will be archived for up to 90 days following the presentation dates.

About
ALX Oncology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology’s lead product candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents. ALX Oncology intends to continue clinical development of ALX148 for the treatment of a range of solid tumor indications as well as myelodysplastic syndromes and acute myeloid lymphoma. For more information, please visit ALX Oncology’s website at www.alxoncology.com. 

 

Investor Contact:

Peter Garcia
Chief Financial Officer, ALX Oncology
(650) 466-7125 Ext. 113
[email protected]

Argot Partners
(212)-600-1902
[email protected]

Media Contact:

Karen Sharma
MacDougall
(781) 235-3060
[email protected]

NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at two upcoming virtual investor conferences in December:

• Piper Sandler 32nd Annual Virtual Healthcare Conference
• Evercore ISI 3^rd Annual HealthCONx Virtual Conference on Thursday, December 3, 2020 at 12:10pm ET

A webcast of the live Evercore presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. A replay of the pre-recorded Piper fireside chat is currently available on the Company’s website. The webcasts will be archived on the Company’s website for 90 days following the presentation.

About 
Protara
 
Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Blaine Davis
Protara Therapeutics
[email protected]
646-844-0337